|
|
||||||||
Correspondence to:
Xian-cheng Jiang
Phospholipid transfer protein gene knock-out (Pltp KO) mice have defective transfer of very low density lipoprotein (VLDL) phospholipids into high density lipoprotein (HDL) and markedly decreased HDL levels (Jiang et al. 1999. J. Clin. Invest. 103: 907;914). These animals also accumulated VLDL- and LDL-sized lipoproteins on a high saturated fat diet. The goals of this study were to further characterize the abnormal lipoproteins of Pltp KO mice and to determine the mechanisms responsible for low HDL levels. A lipoprotein fraction enriched in lamellar structures was isolated from the low density lipoprotein (LDL) region and was shown to be phospholipid- and free cholesterol-rich and to have apoA-IV (55%) and apoE (25%) as major apolipoproteins. The lamellar lipoproteins accumulating in these mice probably represent surface material derived from triglyceride-rich lipoproteins (TRL). The HDL was found to be protein-rich (primarily apoA-I) and specifically depleted in phosphatidylcholine (PC) (28% in wild-type mice (WT) vs. 15% in Pltp KO mice, P < 0.001). Unexpectedly, turnover studies using autologous HDL revealed a profound 4-fold increase in the catabolism of HDL protein and cholesteryl ester in Pltp KO mice compared to wild-type, with minor differences in synthesis rates. In contrast, injection of WT mouse HDL into Pltp KO mice showed only a 2-fold increase in fractional catabolism. Reminiscent of the defect in Tangier disease, the failure of transfer of PC from TRL into the HDL fraction results in dramatic hypercatabolism of HDL.
These results suggest that defective phospholipid transfer from TRL into HDL, arising from decreased lipolysis or decreased PLTP activity, could lead to hypoalphalipoproteinemia characterized by hypercatabolism of HDL protein.Qin, S., K. Kawano, C. Bruce, M. Lin, C. Bisgaier, A. R. Tall, and X-c. Jiang. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J. Lipid Res. 2000. 41: 269;276.
Supplementary key words:
HDL, lipoproteins, apolipoproteins, phospholipids, fractional catabolic rate
Copyright © 2000 by Lipid Research, Inc.
Original Article
Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
Shucun Qina,
Koichi Kawanoa,
Can Brucea,
Min Lina,
Charles Bisgaierb,
Alan R. Talla, and
Xian-cheng Jianga
a Division of Molecular Medicine, Department of Medicine, Columbia University, New York NY 10032
b Esperion Therapeutics, Inc., Ann Arbor, MI 48108
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Lyly, S. K. Marjavaara, A. Kyttala, K. Uusi-Rauva, K. Luiro, O. Kopra, L. O. Martinez, K. Tanhuanpaa, N. Kalkkinen, A. Suomalainen, et al. Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism Hum. Mol. Genet., May 15, 2008; 17(10): 1406 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shelly, L. Royer, T. Sand, H. Jensen, and Y. Luo Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice J. Lipid Res., April 1, 2008; 49(4): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Valenta, J. J. Bulgrien, D. J. Bonnet, and L. K. Curtiss Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency J. Lipid Res., January 1, 2008; 49(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Kiss, N. Kavaslar, K.-i. Okuhira, M. W. Freeman, S. Walter, R. W. Milne, R. McPherson, and Y. L. Marcel Genetic Etiology of Isolated Low HDL Syndrome: Incidence and Heterogeneity of Efflux Defects Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sarov-Blat, R. S. Kiss, B. Haidar, N. Kavaslar, M. Jaye, M. Bertiaux, K. Steplewski, M. R. Hurle, D. Sprecher, R. McPherson, et al. Predominance of a Proinflammatory Phenotype in Monocyte-Derived Macrophages From Subjects With Low Plasma HDL-Cholesterol Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1115 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vikstedt, D. Ye, J. Metso, R. B. Hildebrand, T. J.C. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck Macrophage Phospholipid Transfer Protein Contributes Significantly to Total Plasma Phospholipid Transfer Activity and Its Deficiency Leads to Diminished Atherosclerotic Lesion Development Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Haidar, R. S. Kiss, L. Sarov-Blat, R. Brunet, C. Harder, R. McPherson, and Y. L. Marcel Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux J. Biol. Chem., December 29, 2006; 281(52): 39971 - 39981. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Klein, V. Deckert, M. Schneider, F. Dutrillaux, A. Hammann, A. Athias, N. Le Guern, J.-P. Pais de Barros, C. Desrumaux, D. Masson, et al. {alpha}-Tocopherol Modulates Phosphatidylserine Externalization in Erythrocytes: Relevance in Phospholipid Transfer Protein-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2160 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lee-Rueckert, R. Vikstedt, J. Metso, C. Ehnholm, P. T. Kovanen, and M. Jauhiainen Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells J. Lipid Res., August 1, 2006; 47(8): 1725 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Dallinga-Thie, A. van Tol, H. Hattori, P. C.N. Rensen, E. J.G. Sijbrands, and for the Diabetes Atorvastatin Lipid Intervention ( Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein e? Diabetes, May 1, 2006; 55(5): 1491 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ji, G. F. Watts, A. G. Johnson, D. C. Chan, E. M. M. Ooi, K.-A. Rye, A. P. Serone, and P. H. R. Barrett High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 973 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nilsson and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J. Lipid Res., January 1, 2006; 47(1): 154 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Wu and D. E. Cohen Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1067 - G1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Janis, S. Siggins, E. Tahvanainen, R. Vikstedt, K. Silander, J. Metso, A. Aromaa, M.-R. Taskinen, V. M. Olkkonen, M. Jauhiainen, et al. Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample J. Lipid Res., December 1, 2004; 45(12): 2303 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Brown, A. Gauthier, R. J. Parks, R. McPherson, D. L. Sparks, J. R. Schultz, and Z. Yao Severe Hypoalphalipoproteinemia in Mice Expressing Human Hepatic Lipase Deficient in Binding to Heparan Sulfate Proteoglycan J. Biol. Chem., October 8, 2004; 279(41): 42403 - 42409. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yan, M. Navab, C. Bruce, A. M. Fogelman, and X.-C. Jiang PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity J. Lipid Res., October 1, 2004; 45(10): 1852 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Webb, M. C. de Beer, B. F. Asztalos, N. Whitaker, D. R. van der Westhuyzen, and F. C. de Beer Remodeling of HDL remnants generated by scavenger receptor class B type I J. Lipid Res., September 1, 2004; 45(9): 1666 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lie, R. de Crom, T. van Gent, R. van Haperen, L. Scheek, F. Sadeghi-Niaraki, and A. van Tol Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins J. Lipid Res., May 1, 2004; 45(5): 805 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siggins, M. Karkkainen, J. Tenhunen, J. Metso, E. Tahvanainen, V. M. Olkkonen, M. Jauhiainen, and C. Ehnholm Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA J. Lipid Res., February 1, 2004; 45(2): 387 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siggins, M. Jauhiainen, V. M. Olkkonen, J. Tenhunen, and C. Ehnholm PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma J. Lipid Res., September 1, 2003; 44(9): 1698 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. P. Yang, D. Yan, C. Qiao, R. J. Liu, J.-G. Chen, J. Li, M. Schneider, L. Lagrost, X. Xiao, and X.-C. Jiang Increased Atherosclerotic Lesions in ApoE Mice With Plasma Phospholipid Transfer Protein Overexpression Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1601 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Hudgins, T. S. Parker, D. M. Levine, B. R. Gordon, S. D. Saal, X.-c. Jiang, C. E. Seidman, J. D. Tremaroli, J. Lai, and A. L. Rubin A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers J. Lipid Res., August 1, 2003; 44(8): 1489 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vuletic, L.-W. Jin, S. M. Marcovina, E. R. Peskind, T. Moller, and J. J. Albers Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease J. Lipid Res., June 1, 2003; 44(6): 1113 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mardones, A. Pilon, M. Bouly, D. Duran, T. Nishimoto, H. Arai, K. F. Kozarsky, M. Altayo, J. F. Miquel, G. Luc, et al. Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in Mice J. Biol. Chem., February 28, 2003; 278(10): 7884 - 7890. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Haperen, A. van Tol, T. van Gent, L. Scheek, P. Visser, A. van der Kamp, F. Grosveld, and R. de Crom Increased Risk of Atherosclerosis by Elevated Plasma Levels of Phospholipid Transfer Protein J. Biol. Chem., December 6, 2002; 277(50): 48938 - 48943. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lie, R. de Crom, T. van Gent, R. van Haperen, L. Scheek, I. Lankhuizen, and A. van Tol Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion J. Lipid Res., November 1, 2002; 43(11): 1875 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. R. Hopkins, Y. Huang, J. G. McGuire, and R. E. Pitas Evidence for differential effects of apoE3 and apoE4 on HDL metabolism J. Lipid Res., November 1, 2002; 43(11): 1881 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cao, T. P. Beyer, X. P. Yang, R. J. Schmidt, Y. Zhang, W. R. Bensch, R. F. Kauffman, H. Gao, T. P. Ryan, Y. Liang, et al. Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo J. Biol. Chem., October 11, 2002; 277(42): 39561 - 39565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Murdoch, M. C. Carr, H. Kennedy, J. D. Brunzell, and J. J. Albers Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution J. Lipid Res., August 1, 2002; 43(8): 1256 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gander, P. Eller, S. Kaser, I. Theurl, D. Walter, T. Sauper, A. Ritsch, J. R. Patsch, and B. Foger Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein J. Lipid Res., April 1, 2002; 43(4): 636 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Murdoch, G. Wolfbauer, H. Kennedy, S. M. Marcovina, M. C. Carr, and J. J. Albers Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement J. Lipid Res., February 1, 2002; 43(2): 281 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gotto Jr Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease : A Working Group Report Circulation, May 1, 2001; 103(17): 2213 - 2218. [Full Text] [PDF] |
||||
![]() |
H. M. Colhoun, L. M. Scheek, M. B. Rubens, T. Van Gent, S. R. Underwood, J. H. Fuller, and A. Van Tol Lipid Transfer Protein Activities in Type 1 Diabetic Patients Without Renal Failure and Nondiabetic Control Subjects and Their Association With Coronary Artery Calcification Diabetes, March 1, 2001; 50(3): 652 - 659. [Abstract] [Full Text] |
||||
![]() |
A. R. Tall, X.-c. Jiang, Y. Luo, and D. Silver 1999 George Lyman Duff Memorial Lecture : Lipid Transfer Proteins, HDL Metabolism, and Atherogenesis Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1185 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawano, S.-C. Qin, M. Lin, A. R. Tall, and X.-c. Jiang Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein Have Nonoverlapping Functions in Vivo J. Biol. Chem., September 15, 2000; 275(38): 29477 - 29481. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Urizar, D. H. Dowhan, and D. D. Moore The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression J. Biol. Chem., December 8, 2000; 275(50): 39313 - 39317. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. McManus, B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel Proteolytic Degradation and Impaired Secretion of an Apolipoprotein A-I Mutant Associated with Dominantly Inherited Hypoalphalipoproteinemia J. Biol. Chem., June 8, 2001; 276(24): 21292 - 21302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Scott, D. C. McManus, V. Franklin, A. G. McKenzie, T. Neville, D. L. Sparks, and Y. L. Marcel The N-terminal Globular Domain and the First Class A Amphipathic Helix of Apolipoprotein A-I Are Important for Lecithin:Cholesterol Acyltransferase Activation and the Maturation of High Density Lipoprotein in Vivo J. Biol. Chem., December 21, 2001; 276(52): 48716 - 48724. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |